A J Costello

Summary

Country: Australia

Publications

  1. ncbi request reprint Supratrigonal cystectomy and ileocystoplasty in management of interstitial cystitis
    A J Costello
    Department of Urology, St Vincent s Hospital, Victoria, Australia
    Aust N Z J Surg 70:34-8. 2000
  2. ncbi request reprint Experience with the holmium laser as an endoscopic lithotrite
    A J Costello
    Department of Urology, Royal Melbourne Hospital, Parkville, Victoria, Australia
    Aust N Z J Surg 70:348-50. 2000
  3. ncbi request reprint A randomized, controlled chemoprevention trial of selenium in familial prostate cancer: Rationale, recruitment, and design issues
    A J Costello
    University of Melbourne, Department of Surgery, Division of Urology, Royal Melbourne Hospital, Parkville, Melbourne, Australia
    Urology 57:182-4. 2001
  4. pmc Levels of a subpopulation of platelets, but not circulating endothelial cells, predict early treatment failure in prostate cancer patients after prostatectomy
    C K E Wong
    Australian Prostate Cancer Research Centre at Epworth Hospital, Richmond, Victoria, Australia
    Br J Cancer 107:1564-73. 2012
  5. ncbi request reprint Patient outcomes in the acute recovery phase following robotic-assisted prostate surgery: a prospective study
    Rosemary Watts
    Centre for Clinical Nursing Research, Epworth Hospital Deakin University, 89 Bridge Road, Melbourne, VIC 3121, Australia
    Int J Nurs Stud 46:442-9. 2009
  6. ncbi request reprint Robotic radical prostatectomy in Australia: initial experience
    P J O'Malley
    Department of Urology 3S, Royal Melbourne Hospital, Grattan Street, 3050, Parkville, Vic, Australia
    World J Urol 24:165-70. 2006
  7. ncbi request reprint Adverse events after prostatectomy in Victorian public hospitals
    M Z Ansari
    Epidemiology Unit, Health Care Evaluation, Department of Human Services, Melbourne, Victoria, Australia
    Aust N Z J Surg 68:830-6. 1998
  8. ncbi request reprint Differential response of prostate specific antigen to testosterone surge after luteinizing hormone-releasing hormone analogue in prostate cancer and benign prostatic hyperplasia
    D K Agarwal
    St Vincent s Hospital and Western Hospital, Melbourne, Australia
    BJU Int 85:690-5. 2000
  9. ncbi request reprint An option for prostatectomy in the thrombocytopenic patient: a continued role for the Nd:YAG laser
    P E Dundee
    Department of Urology, Royal Melbourne Hospital, Melbourne, Australia
    Photomed Laser Surg 23:333-4. 2005
  10. ncbi request reprint Case report: holmium laser resection and lasertripsy for intravesical ureterocele with calculus
    M Aron
    Department of Surgery, Division of Urology, Royal Melbourne Hospital, Melbourne, Australia
    Lasers Surg Med 29:82-4. 2001

Collaborators

Detail Information

Publications14

  1. ncbi request reprint Supratrigonal cystectomy and ileocystoplasty in management of interstitial cystitis
    A J Costello
    Department of Urology, St Vincent s Hospital, Victoria, Australia
    Aust N Z J Surg 70:34-8. 2000
    ..The authors' experience with a modified technique of ileocystoplasty following supratrigonal cystectomy performed in five patients with interstitial cystitis is presented here...
  2. ncbi request reprint Experience with the holmium laser as an endoscopic lithotrite
    A J Costello
    Department of Urology, Royal Melbourne Hospital, Parkville, Victoria, Australia
    Aust N Z J Surg 70:348-50. 2000
    ..Holmium laser lithotripsy represents an additional option in the management of urinary tract calculi. We report the results of a cohort of patients with ureteric and bladder calculi treated with this modality...
  3. ncbi request reprint A randomized, controlled chemoprevention trial of selenium in familial prostate cancer: Rationale, recruitment, and design issues
    A J Costello
    University of Melbourne, Department of Surgery, Division of Urology, Royal Melbourne Hospital, Parkville, Melbourne, Australia
    Urology 57:182-4. 2001
    ....
  4. pmc Levels of a subpopulation of platelets, but not circulating endothelial cells, predict early treatment failure in prostate cancer patients after prostatectomy
    C K E Wong
    Australian Prostate Cancer Research Centre at Epworth Hospital, Richmond, Victoria, Australia
    Br J Cancer 107:1564-73. 2012
    ..Our aim was to investigate the potential use of these circulating cells levels as predictors of prostate cancer treatment failure and metastasis...
  5. ncbi request reprint Patient outcomes in the acute recovery phase following robotic-assisted prostate surgery: a prospective study
    Rosemary Watts
    Centre for Clinical Nursing Research, Epworth Hospital Deakin University, 89 Bridge Road, Melbourne, VIC 3121, Australia
    Int J Nurs Stud 46:442-9. 2009
    ..It has many potential benefits for patients with localised prostate cancer over traditional surgical techniques without taking a risk with the oncological result...
  6. ncbi request reprint Robotic radical prostatectomy in Australia: initial experience
    P J O'Malley
    Department of Urology 3S, Royal Melbourne Hospital, Grattan Street, 3050, Parkville, Vic, Australia
    World J Urol 24:165-70. 2006
    ..Increasing availability of this modality will inevitably give rise to further adaptations. We present the initial Australian experience...
  7. ncbi request reprint Adverse events after prostatectomy in Victorian public hospitals
    M Z Ansari
    Epidemiology Unit, Health Care Evaluation, Department of Human Services, Melbourne, Victoria, Australia
    Aust N Z J Surg 68:830-6. 1998
    ..The study also sought to identify predictors of adverse events (AE) after prostatectomy, and to compare in-hospital complications between open prostatectomy and transurethral resection of prostate (TURP)...
  8. ncbi request reprint Differential response of prostate specific antigen to testosterone surge after luteinizing hormone-releasing hormone analogue in prostate cancer and benign prostatic hyperplasia
    D K Agarwal
    St Vincent s Hospital and Western Hospital, Melbourne, Australia
    BJU Int 85:690-5. 2000
    ....
  9. ncbi request reprint An option for prostatectomy in the thrombocytopenic patient: a continued role for the Nd:YAG laser
    P E Dundee
    Department of Urology, Royal Melbourne Hospital, Melbourne, Australia
    Photomed Laser Surg 23:333-4. 2005
  10. ncbi request reprint Case report: holmium laser resection and lasertripsy for intravesical ureterocele with calculus
    M Aron
    Department of Surgery, Division of Urology, Royal Melbourne Hospital, Melbourne, Australia
    Lasers Surg Med 29:82-4. 2001
    ..We present the use of this laser in the ablation of an intravesical ureterocele with calculus...
  11. pmc Open-label, phase I dose-escalation study of sodium selenate, a novel activator of PP2A, in patients with castration-resistant prostate cancer
    N M Corcoran
    Department of Surgery, Division of Urology University of Melbourne, Royal Melbourne Hospital, 5th Floor Clinical Sciences Building, Royal Parade, Parkville, Victoria 3050, Australia
    Br J Cancer 103:462-8. 2010
    ..Angiogenesis is fundamental to the progression of many solid tumours including prostate cancer. Sodium selenate is a small, water-soluble, orally bioavailable activator of PP2A phosphatase with anti-angiogenic properties...
  12. ncbi request reprint Day-case holmium laser enucleation of the prostate for gland volumes of < 60 mL: early experience
    T R G Larner
    Department of Urology, Royal Melbourne Hospital, Australia
    BJU Int 91:61-4. 2003
    ..To examine the safety and effectiveness of holmium laser enucleation of the prostate (HoLEP), as a day-case procedure for selected patients...
  13. ncbi request reprint Minimally invasive radical prostatectomy: now safe and efficacious
    A J Costello
    Department of Surgery, University of Melbourne, Royal Melbourne Hospital, Melbourne, Victoria, Australia
    ANZ J Surg 74:1038. 2004
  14. ncbi request reprint Interleukin-6: minor player or starring role in the development of hormone-refractory prostate cancer?
    N M Corcoran
    Department of Urology, Royal Melbourne Hospital, Parkville, Victoria, Australia
    BJU Int 91:545-53. 2003